Cyclooxygenase-2-derived prostanoids reduce inward arterial remodeling induced by blood flow reduction in old obese Zucker rat mesenteric arteries

Vascular Pharmacology

Volumn 58, Issue 5-6, 2013, Pages 356-362

  Vessières, Emilie ^d   Belin de Chantemèle, Eric J ^a   Guihot, Anne Laure ^b   Jardel, Alain ^a   Toutain, Bertrand ^a   Loufrani, Laurent ^b,d   Henrion, Daniel ^c,d  

^a UNIVERSITÉ D'ANGERS   (France)

^b CNRS   (France)

^c UNIVERSITÉ D'ANGERS   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Blood flow; Cyclooxygenase 2; Metabolic syndrome; Remodeling; Resistance arteries

Indexed keywords

CYCLOOXYGENASE 2; PHENYLEPHRINE; PROSTACYCLIN; PROSTAGLANDIN F1 ALPHA; PROSTANOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY DIAMETER; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; IN VIVO STUDY; MALE; MESENTERIC ARTERY; MESENTERIC ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ZUCKER RAT;

6-KETOPROSTAGLANDIN F1 ALPHA; AGE FACTORS; ANIMALS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; MALE; MESENTERIC ARTERIES; OBESITY; PHENYLEPHRINE; RATS; RATS, ZUCKER; VASOCONSTRICTION;

EID: 84877594328     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2013.03.001     Document Type: Article

References (49)

1. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 1998, 15:539-553.
2. Bakker E.N., Matlung H.L., Bonta P., de Vries C.J., van Rooijen N., Vanbavel E. Blood flow-dependent arterial remodelling is facilitated by inflammation but directed by vascular tone. Cardiovasc. Res. 2008, 78:341-348.
3. Baron-Menguy C., Toutain B., Cousin M., Dumont O., Guihot A.L., Vessieres E., Subra J.F., Custaud M.A., Loufrani L., Henrion D. Involvement of angiotensin II in the remodeling induced by a chronic decrease in blood flow in rat mesenteric resistance arteries. Hypertens. Res. 2010, 33:857-866.
4. Belin de Chantemele E.J., Vessieres E., Guihot A.L., Toutain B., Loufrani L., Henrion D. Cyclooxygenase-2 preserves flow-mediated remodelling in old obese Zucker rat mesenteric arteries. Cardiovasc. Res. 2010, 86:516-525.
5. Belin de Chantemele E.J., Vessieres E., Dumont O., Guihot A.L., Toutain B., Loufrani L., Henrion D. Reactive oxygen species are necessary for high flow (shear stress)-induced diameter enlargement of rat resistance arteries. Microcirculation 2009, 16:391-402.
6. Bolla M., Matrougui K., Loufrani L., Maclouf J., Levy B., Levy-Toledano S., Habib A., Henrion D. p38 mitogen-activated protein kinase activation is required for thromboxane- induced contraction in perfused and pressurized rat mesenteric resistance arteries. J. Vasc. Res. 2002, 39:353-360.
7. Bouvet C., Belin de Chantemele E., Guihot A.L., Vessieres E., Bocquet A., Dumont O., Jardel A., Loufrani L., Moreau P., Henrion D. Flow-induced remodeling in resistance arteries from obese Zucker rats is associated with endothelial dysfunction. Hypertension 2007, 50:248-254.
8. Buus C.L., Pourageaud F., Fazzi G.E., Janssen G., Mulvany M.J., De Mey J.G. Smooth muscle cell changes during flow-related remodeling of rat mesenteric resistance arteries. Circ. Res. 2001, 89:180-186.
9. Dowell F.J., Henrion D., Duriez M., Michel J.B. Vascular reactivity in mesenteric resistance arteries following chronic nitric oxide synthase inhibition in Wistar rats. Br. J. Pharmacol. 1996, 117:341-346.
10. Driss A., Devaux C., Henrion D., Duriez M., Thuillez C., Levy B.I., Michel J.B. Hemodynamic stresses induce endothelial dysfunction and remodeling of pulmonary artery in experimental compensated heart failure. Circulation 2000, 101:2764-2770.
11. Enevoldsen L.H., Stallknecht B., Fluckey J.D., Galbo H. Effect of exercise training on in vivo insulin-stimulated glucose uptake in intra-abdominal adipose tissue in rats. Am. J. Physiol. Endocrinol. Metab. 2000, 278:E25-E34.
12. Freidja M.L., Toutain B., Caillon A., Desquiret V., Lambert D., Loufrani L., Procaccio V., Henrion D. Heme oxygenase 1 is differentially involved in blood flow-dependent arterial remodeling: role of inflammation, oxidative stress, and nitric oxide. Hypertension 2011, 58:225-231.
13. Freidja M.L., Tarhouni K., Toutain B., Fassot C., Loufrani L., Henrion D. The AGE-breaker ALT-711 restores high blood flow-dependent remodeling in mesenteric resistance arteries in a rat model of type 2 diabetes. Diabetes 2012, 61:1562-1572.
14. Gendron M.E., Thorin-Trescases N., Villeneuve L., Thorin E. Aging associated with mild dyslipidemia reveals that COX-2 preserves dilation despite endothelial dysfunction. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H451-H458.
15. Goodwill A.G., Frisbee J.C. Oxidant stress and skeletal muscle microvasculopathy in the metabolic syndrome. Vasc. Pharmacol. 2012, 57:150-159.
16. Henrion D. Pressure and flow-dependent tone in resistance arteries. Role of myogenic tone. Arch. Mal. Coeur Vaiss. 2005, 98:913-921.
17. Henrion D., Laher I., Laporte R., Bevan J.A. Angiotensin II amplifies arterial contractile response to norepinephrine without increasing Ca++ influx: role of protein kinase C. J. Pharmacol. Exp. Ther. 1992, 261:835-840.
18. Henrion D., Dowell F.J., Levy B.I., Michel J.B. In vitro alteration of aortic vascular reactivity in hypertension induced by chronic NG-nitro-L-arginine methyl ester. Hypertension 1996, 28:361-366.
19. Herman W.H., Zimmet P. Type 2 diabetes: an epidemic requiring global attention and urgent action. Diabetes Care 2012, 35:943-944.
20. Hu G., Qiao Q., Tuomilehto J., Balkau B., Borch-Johnsen K., Pyorala K. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch. Intern. Med. 2004, 164:1066-1076.
21. Iannuzzi A., De Michele M., Bond M.G., Sacchetti L., Fortunato G., Salvatore F., Mattiello A., Panico S., Rubba P. Carotid artery remodeling in middle-aged women with the metabolic syndrome (from the "Progetto ATENA" study). Am. J. Cardiol. 2005, 96:1162-1165.
22. Johnson P.R., Stern J.S., Horwitz B.A., Harris R.E., Greene S.F. Longevity in obese and lean male and female rats of the Zucker strain: prevention of hyperphagia. Am. J. Clin. Nutr. 1997, 66:890-903.
23. Kauffenstein G., Laher I., Matrougui K., Guerineau N.C., Henrion D. Emerging role of G protein-coupled receptors in microvascular myogenic tone. Cardiovasc. Res. 2012, 95:223-232.
24. Kurtz T.W., Morris R.C., Pershadsingh H.A. The Zucker fatty rat as a genetic model of obesity and hypertension. Hypertension 1989, 13:896-901.
25. Lemkens P., Nelissen J., Meens M.J., Fazzi G.E., Janssen G.J., Debets J.J., Janssen B.J., Schiffers P.M., De Mey J.G. Impaired flow-induced arterial remodeling in DOCA-salt hypertensive rats. Hypertens. Res. 2012, 35:1093-1101.
26. Loufrani L., Levy B.I., Henrion D. Defect in microvascular adaptation to chronic changes in blood flow in mice lacking the gene encoding for dystrophin. Circ. Res. 2002, 91:1183-1189.
27. Loufrani L., Matrougui K., Li Z., Levy B.I., Lacolley P., Paulin D., Henrion D. Selective microvascular dysfunction in mice lacking the gene encoding for desmin. FASEB J. 2002, 16:117-119.
28. Morrison A., Ramey D.R., van Adelsberg J., Watson D.J. Systematic review of trials of the effect of continued use of oral non-selective NSAIDs on blood pressure and hypertension. Curr. Med. Res. Opin. 2007, 23:2395-2404.
29. Onat A. Metabolic syndrome: nature, therapeutic solutions and options. Expert. Opin. Pharmacother. 2011, 12:1887-1900.
30. Pourageaud F., De Mey J.G. Structural properties of rat mesenteric small arteries after 4-wk exposure to elevated or reduced blood flow. Am. J. Physiol. 1997, 273:H1699-H1706.
31. Prasad H., Ryan D.A., Celzo M.F., Stapleton D. Metabolic syndrome: definition and therapeutic implications. Postgrad. Med. 2012, 124:21-30.
32. Prewitt R.L., Rice D.C., Dobrian A.D. Adaptation of resistance arteries to increases in pressure. Microcirculation 2002, 9:295-304.
33. Rao C., Adair T., Bain C., Doi S.A. Mortality from diabetic renal disease: a hidden epidemic. Eur. J. Public Health 2012, 22:280-284.
34. Retailleau K., Belin de Chantemele E.J., Chanoine S., Guihot A.L., Vessieres E., Toutain B., Faure S., Bagi Z., Loufrani L., Henrion D. Reactive oxygen species and cyclooxygenase 2-derived thromboxane A2 reduce angiotensin II type 2 receptor vasorelaxation in diabetic rat resistance arteries. Hypertension 2010, 55:339-344.
35. Retailleau K., Toutain B., Galmiche G., Fassot C., Sharif-Naeini R., Kauffenstein G., Mericskay M., Duprat F., Grimaud L., Merot J., Lardeux A., Pizard A., Baudrie V., Jeunemaitre X., Feil R., Gothert J.R., Lacolley P., Henrion D., Li Z., Loufrani L. Selective involvement of serum response factor in pressure-induced myogenic tone in resistance arteries. Arterioscler. Thromb. Vasc. Biol. 2013, 33:339-346.
36. Rocic P. Why is coronary collateral growth impaired in type II diabetes and the metabolic syndrome?. Vasc. Pharmacol. 2012, 57:179-186.
37. Romanko O.P., Stepp D.W. Reduced constrictor reactivity balances impaired vasodilation in the mesenteric circulation of the obese Zucker rat. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H2097-H2102.
38. Sanchez A., Contreras C., Martinez P., Villalba N., Benedito S., Garcia-Sacristan A., Salaices M., Hernandez M., Prieto D. Enhanced cyclooxygenase 2-mediated vasorelaxation in coronary arteries from insulin-resistant obese Zucker rats. Atherosclerosis 2010, 213:392-399.
39. Schofield I., Malik R., Izzard A., Austin C., Heagerty A. Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation 2002, 106:3037-3043.
40. Stepp D.W., Boesen E.I., Sullivan J.C., Mintz J.D., Hair C.D., Pollock D.M. Obesity augments vasoconstrictor reactivity to angiotensin II in the renal circulation of the Zucker rat. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H2537-H2542.
41. Tarhouni K., Guihot A.L., Freidja M.L., Toutain B., Henrion B., Baufreton C., Pinaud F., Procaccio V., Grimaud L., Ayer A., Loufrani L., Lenfant F., Arnal J.F., Henrion D. Key role of estrogens and endothelial estrogen receptor alpha in blood flow-mediated remodeling of resistance arteries. Arterioscler. Thromb. Vasc. Biol. 2013, 33:605-611.
42. Thomas G.N., Chook P., Qiao M., Huang X.S., Leong H.C., Celermajer D.S., Woo K.S. Deleterious impact of "high normal" glucose levels and other metabolic syndrome components on arterial endothelial function and intima-media thickness in apparently healthy Chinese subjects: the CATHAY study. Arterioscler. Thromb. Vasc. Biol. 2004, 24:739-743.
43. Traupe T., Lang M., Goettsch W., Munter K., Morawietz H., Vetter W., Barton M. Obesity increases prostanoid-mediated vasoconstriction and vascular thromboxane receptor gene expression. J. Hypertens. 2002, 20:2239-2245.
44. van den Akker J., Schoorl M.J., Bakker E.N., Vanbavel E. Small artery remodeling: current concepts and questions. J. Vasc. Res. 2009, 47:183-202.
45. van den Akker J., VanBavel E., van Geel R., Matlung H.L., Guvenc Tuna B., Janssen G.M., van Veelen P.A., Boelens W.C., De Mey J.G., Bakker E.N. The redox state of transglutaminase 2 controls arterial remodeling. PLoS One 2011, 6:e23067.
46. Vessieres E., Freidja M.L., Loufrani L., Fassot C., Henrion D. Flow (shear stress)-mediated remodeling of resistance arteries in diabetes. Vasc. Pharmacol. 2012, 57:173-178.
47. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
48. Willette R.N., Eybye M.E., Olzinski A.R., Behm D.J., Aiyar N., Maniscalco K., Bentley R.G., Coatney R.W., Zhao S., Westfall T.D., Doe C.P. Differential effects of p38 mitogen-activated protein kinase and cyclooxygenase 2 inhibitors in a model of cardiovascular disease. J. Pharmacol. Exp. Ther. 2009, 330:964-970.
49. Yildiz O. Vascular smooth muscle and endothelial functions in aging. Ann. N. Y. Acad. Sci. 2007, 1100:353-360.